Received Sep 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | 2 | Y014090 | IM / RL |
| PNC15 | PNEUMO (VAXNEUVANCE) | MERCK & CO. INC. | 1 | Z003633 | IM / LL |
patient developed an erythematous rash on bilateral lower extremities (mostly from knees down) and minimal similar rash on the back, as well as crying and irritability within 5-10 minutes of receiving both vaccines. Pte was given Benadryl 12.5mg/5ml 2.5 ml orally, rash resolved withing 8 minutes after she took the Benadryl, patient was monitored for another 40 minutes and then discharged home after no more side effects or allergic reactions
None
None
Tri-Vi-Sol
NKDA
none